ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,213Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 559

$513K Total Retail Price of All Prescriptions

Rank: 29 out of 559

568 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 11,166 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 953 803 1 1
LEVOTHYROXINE SODIUM 886 788 2 2
AMLODIPINE BESYLATE 645 577 3 6
LOVASTATIN 587 553 4 10
METFORMIN HCL 526 437 5 5
OMEPRAZOLE 380 285 6 4
SIMVASTATIN 343 242 7 3
ALENDRONATE SODIUM 338 323 8 13
HYDROCHLOROTHIAZIDE 300 243 9 8
GABAPENTIN 297 233 10 9
METOPROLOL SUCCINATE 293 271 11 16
FUROSEMIDE 288 258 12 11
LOSARTAN POTASSIUM 267 253 13 14
HYDROCODONE-ACETAMINOPHEN 216 179 S3 14 7
ATENOLOL 202 187 15 15
GLIMEPIRIDE 196 158 16 53
PRAVASTATIN SODIUM 192 160 17 35
RANITIDINE HCL 141 100 18 26
SERTRALINE HCL 136 92 19 19
ACETAMINOPHEN-CODEINE 120 98 S3 20 83
ZOLPIDEM TARTRATE 118 115 21 17
PANTOPRAZOLE SODIUM 113 110 22 41
FLUTICASONE PROPIONATE 108 75 23 22
GLIPIZIDE 106 94 24 31
POTASSIUM CHLORIDE 105 94 25 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 94 26 18
METOPROLOL TARTRATE 101 101 27 12
DONEPEZIL HCL 97 97 28 36
CITALOPRAM HBR 93 59 29 21
OXYCODONE-ACETAMINOPHEN 91 74 S2 30 44
PAROXETINE HCL 89 74 31 48
IBUPROFEN 85 65 32 30
ZETIA 85 82 32 101
ATORVASTATIN CALCIUM 84 71 34 20
OXYBUTYNIN CHLORIDE 81 73 35 62
PROAIR HFA 81 70 35 29
HYDRALAZINE HCL 78 64 37 143
DOXAZOSIN MESYLATE 75 75 38 43
CLOPIDOGREL 72 64 39 51
HYDROXYZINE HCL 72 56 R 39 108
DILTIAZEM ER 72 72 39 118
AMITRIPTYLINE HCL 69 36 R 42 58
FAMOTIDINE 68 60 43 93
LEVEMIR FLEXPEN 64 63 44 127
FENOFIBRATE 63 55 45 69
CLONIDINE HCL 62 44 46 68
AZITHROMYCIN 62 52 46 39
BENAZEPRIL HCL 62 62 46 85
ALLOPURINOL 62 46 46 34
TRAZODONE HCL 59 38 50 28
INSULIN SYRINGE 59 44 50 65
DICLOFENAC SODIUM 57 50 52 81
CRESTOR 57 40 52 33
TRIAMTERENE-HCTZ 56 52 54 47
MIRTAZAPINE 56 52 54 61
NABUMETONE 55 45 56 121
LANTUS SOLOSTAR 55 36 56 136
PLAVIX 54 51 58 76
GLYBURIDE 54 43 R 58 45
PEN NEEDLE 53 36 60 150
FELODIPINE ER 51 33 61 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.